A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides

Vingtdeux, V.; Zhao, H.; Chandakkar, P.; Acker, C.; Davies, P.; Marambaud, P.

doi:10.1101/084913

Home/Archive/bioRxiv

bioRxiv · 10.1101/084913

A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides

Vingtdeux, V.·Zhao, H.·Chandakkar, P.·Acker, C.·Davies, P.·Marambaud, P.

View original source ↗Export metadata ↓

Abstract

Strategies aimed at reducing cerebral accumulation of the amyloid-{beta} (A{beta}) peptides have therapeutic potential in Alzheimers disease (AD). A{beta} immunization has proven to be effective at promoting A{beta} clearance in animal models but adverse effects have hampered its clinical evaluation. The first anti-A{beta} immunization clinical trial, which assessed a full-length A{beta}1-42 vaccine, increased the risk of encephalitis most likely because of autoimmune pro-inflammatory T helper 1 (Th1) response against all forms of A{beta}. Immunization against less abundant but potentially more pathologically relevant A{beta} products, such as N-terminally-truncated pyroglutamate-3 A{beta} (A{beta}pE3), could provide efficacy and improve tolerability in A{beta} immunotherapy. Here, we describe a selective vaccine against A{beta}pE3 using the diphtheria toxin mutant CRM197 as carrier protein for epitope presentation. CRM197 is currently used in licensed vaccines and has demonstrated excellent immunogenicity and safety in humans. In mice, our A{beta}pE3:CRM197 vaccine triggered the production of specific anti-A{beta}pE3 antibodies that did not cross-react with A{beta}1-42, non-cyclized A{beta}E3, or N-terminally-truncated pyroglutamate-11 A{beta} (A{beta}pE11). A{beta}pE3:CRM197 antiserum strongly labeled A{beta}pE3 in insoluble protein extracts and decorated cortical amyloid plaques in human AD brains. Anti-A{beta}pE3 antibodies were almost exclusively of the IgG1 isotype, suggesting an anti-inflammatory Th2 response bias to the A{beta}pE3:CRM197 vaccine. To the best of our knowledge, this study shows for the first time that CRM197 has potential as a safe and suitable vaccine carrier for active and selective immunization against specific protein sequence modifications or conformations, such as A{beta}pE3.

Source connections

Published article ↗

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Vingtdeux, V., Zhao, H., Chandakkar, P., Acker, C., Davies, P., Marambaud, P.. 2016-11-04. A modification-specific peptide-based immunization approach using CRM197 carrier protein: Development of a selective vaccine against pyroglutamate Aβ peptides. https://doi.org/10.1101/084913

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Human iEEG recordings during audiovisual speech violations support and extend predictive routing models

Rather than constantly reconstructing the world solely through sensory input, predictive processing theories posit that the brain utilizes predictions maintained as internal representations to guide sensory processing. An emerging model, predictive routing, proposes that an interplay between neuronal gamma (40-150 Hz) and alpha-beta (10-30 Hz) rhythms implements a dynamic mechanism for predictive processing. Namely, predictions enhance alpha-beta oscillations that suppress gamma activity during the processing of predicted inputs. While this model is supported by animal studies, its validity has not been fully explored within the human brain. The present study addresses this by leveraging human intracranial EEG (iEEG) recordings across superior temporal and prefrontal/premotor areas of seven presurgical epilepsy patients during an audiovisual speech paradigm. We calculated iEEG power in the theta, alpha-beta, and high gamma bands during simple auditory deviance, multisensory integration, and a condition where an incongruent visual cue (lip movements) clashed with an auditory stimulus (a syllable), creating audiovisual incongruence that can elicit the McGurk illusion. Results revealed increased high-gamma and decreased alpha-beta power in the superior temporal cortex in response to auditory deviance and the McGurk condition, while frontal areas, despite reflecting a similar decrease in alpha-beta power, did not present this high gamma prediction error signal. Instead, the theta band revealed a strong prediction error signal in the McGurk condition, consistent with theories on the role of theta in reorganizing cortical networks. These results both support and extend existing predictive routing models for human-specific forms of predictive processing.

neuroscience↗

bioRxiv2026

A Unified World Model in Human Posterior Parietal Cortex

How does the brain understand the physical world, predict future events, and plan actions? Are these problems solved by a unified world model, as hypothesized by cognitive scientists and artificial intelligence researchers? Posterior parietal cortex has been implicated in all these functions, but whether the same neurons support each of them is unknown. We recorded from the superior parietal lobule (SPL) of two tetraplegic participants implanted with microelectrode arrays. SPL units preferentially engaged by intuitive physics, judging block-tower stability and viewing naturalistic physical events, also predicted whether moving objects would collide hundreds of milliseconds before contact, generalizing between different physical scenarios. These populations also encoded which hand action the participant intended to perform. These findings identify SPL as a substrate for physical world modeling.

neuroscience↗

bioRxiv2026

Cortical long-range dynamics track excitation-inhibition balance across cognitive states and organizational principles

A fundamental question in systems neuroscience is how the brain's excitation-inhibition (E/I) balance shapes the temporal structure of neural activity and whether we can non-invasively recover this relationship from neural scaling properties. We show that MRS-derived E/I balance is expressed in long-range temporal dynamics and constrained by cytoarchitecture. The laminar organisation of inhibitory circuits, spanning agranular to granular cortex, determines how faithfully regional dynamics reflect E/I balance. This neurochemical signature is state-dependent: its relationship with cortical dynamics reverses during task engagement, consistent with traversal of dynamical regimes around a critical point. It extends beyond fMRI to arousal-linked dynamics, indexed by pupil diameter and microsaccades, indicating a global mode of cortical state rather than a regionally isolated property. The imprint of E/I balance on long-range dynamics follows the sensory-association axis at rest, and is reconfigured during task engagement. These findings establish E/I balance as a neurochemical quantity with structured, scalable signatures across the temporal and spatial organization of the human cortex.

neuroscience↗